Mr. Alnoor Nathoo reports

MEDBRIGHT AI ANNOUNCES BETA CUSTOMER FOR MEDMATRIX, THE AI-DRIVEN DATA AND ANALYTICS PLATFORM

The Dermatology Institute & Skin Care Center (DISCC), a leader in dermatologic services in Southern California, has chosen to implement MedMatrix to improve its clinic operations. MedMatrix is an industry-leading AI-powered (artificial intelligence) data analytics platform developed and operated by Healthcare Accretion AI, a Medbright AI Investments Inc. investment. MedMatrix harnesses the power of artificial intelligence to evaluate and analyze key aspects of health care facilities, including patient needs and resource matching, revenue cycle management, patient demographics, facility geography and competition. Through its advanced AI and data analytics capabilities, MedMatrix works alongside health care professionals to optimize each of these critical areas, resulting in more efficient clinic operations and improved patient outcomes.

DISCC specializes in cosmetic, medical and surgical dermatology in Los Angeles. Led by board-certified dermatologist Dr. Paul Yamauchi, MD, PhD, the practice offers state-of-the-art dermatology services to provide the highest-quality skin care possible. Dr. Yamauchi is a nationally recognized dermatologist and a key opinion leader in the subject of psoriatic, atopic dermatitis and other inflammatory skin disorders. In addition to his role as medical director for DISCC, he is also the medical director for Clinical Science Institute, the clinical assistant professor of dermatology for the David Geffen School of Medicine and an adjunct associate professor of the John Wayne Cancer Institute.

"There is clearly a need for AI to help operations and the efficiency of clinics," Dr. Yamauchi said. "I'm excited to see the improvements we can make as a result of using the MedMatrix platform."

Michael Dalsin, chairman of Healthcare Accretion AI, said "We are pleased to have DISCC and Dr. Yamauchi as customers of the MedMatrix platform and are looking forward to showing the results of our early operations with DISCC in the coming months."

About Medbright AI Investments Inc.

Medbright AI is a capital allocator focused on investing in health care technology companies. The team at Medbright prides itself on unparalleled access to opportunities as well as structuring unique and advantageous investments. Medbright's mission is to construct a portfolio of synergistic investments to generate superior returns for shareholders. Medbright will focus on significant near-term and midterm high-quality opportunities with strong return potentials while maintaining commitment to governance.

We seek Safe Harbor.